Nitazene Response Act
- Bill Number
- H.R. 8192
- Origin Chamber
- House
- Congress
- 119th Congress, Session 2
- Policy Area
- Crime and Law Enforcement
- Status
- Introduced
- Latest Action
- 2026-04-02: Referred to the House Committee on Energy and Commerce.
- Last Updated
- 2026-04-13T14:39:31Z
AI-Generated Summary
Nitazene Response Act (H.R. 8192)
Purpose
The legislation aims to combat nitazene overdoses—caused by a class of highly potent synthetic opioids—by directing the Secretary of Health and Human Services (HHS) to develop and distribute evidence-based clinical guidelines for effective emergency response.
Key Provisions
- Guidelines Development: HHS must issue updated guidelines covering:
- Best practices for responding to potential nitazene overdoses, including protocols for using naloxone (a medication that reverses opioid overdoses).
- Instructions for emergency departments and hospitals.
- Specific guidance for rural and volunteer emergency medical services (EMS) systems.
- Any other relevant information deemed necessary by HHS.
- Publication Requirement: Guidelines must be posted on the HHS public website within 180 days of enactment.
- Congressional Report: Within one year of enactment, HHS must submit a report to Congress including the guidelines and an explanation of how they will help address nitazene overdoses.
- Definitions:
- Nitazene: Benzimidazole-opioids with structures similar to etonitazene or isotonitazene, including specific substances like etonitazene, clonitazene, metonitazene, and others (covering salts, isomers, etc., that act as mu-opioid receptor agonists).
- Nitazene overdose: Any overdose involving nitazenes or other ultra-potent synthetic opioids.
Significant Changes to Existing Law
This bill introduces new requirements for HHS to create and publicize specialized guidelines on nitazene overdoses. It does not amend existing statutes but adds targeted public health directives without altering prior opioid response laws.
Potential Impacts
- Government Agencies: HHS gains a mandate to produce and report on guidelines, increasing administrative workload but enhancing federal coordination on synthetic opioid crises.
- Citizens: Improves overdose response capabilities, potentially saving lives by standardizing treatments like naloxone use, especially in underserved rural areas.
- No Direct International Relations Impact: Focuses on domestic public health without foreign policy elements.
Main Stakeholders Affected
- Healthcare Providers: Emergency departments, hospitals, rural EMS, and volunteer responders who will follow the new guidelines.
- Federal Government: HHS (leads implementation) and Congress (receives reporting).
- At-Risk Populations: Individuals facing nitazene exposure, including those misusing opioids, benefiting from better emergency care.
- Public Health Community: Benefits from evidence-based tools to tackle emerging synthetic opioid threats.
Notable Legal, Constitutional, or Political Implications
- Legal: Straightforward administrative directive with clear deadlines; enforceable via congressional oversight but no new enforcement mechanisms or penalties.
- Constitutional: Aligns with federal authority over public health (e.g., under the Commerce Clause for interstate drug issues); no apparent free speech, privacy, or due process concerns.
- Political: Addresses a pressing opioid epidemic subset (ultra-potent synthetics), signaling bipartisan interest in targeted, non-criminalizing responses focused on harm reduction rather than enforcement.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Taylor, David J. [R-OH-2]
Recent Actions
- 2026-04-02: Referred to the House Committee on Energy and Commerce.
- 2026-04-02: Introduced in House
- 2026-04-02: Introduced in House
Bill Versions
- Nitazene Response Act — issued 2026-04-02 — PDF (4 pages)